By Sriparna Roy and Sneha S K (Reuters) -Elevance Health said on Tuesday it expects elevated medical costs in its Medicaid business to persist into the next year and possibly subside only in 2027. The comments on the Medicaid business overshadowed the initial enthusiasm around the company's third-quarter profit beat, sending its shares down as much 4% in early trading. Health insurers have been battling with persistently high costs after a churn in enrollement in Medicaid, government plans for low-incom ...